文献速递神经免疫

评估多发性硬化女性体外受精后需使用皮质类固醇的复发风险

Assessing the Risk of Relapse Requiring Corticosteroids After In Vitro Fertilization in Women With Multiple Sclerosis.
PubMed 文献 · Neurology · 2022-10-24

这项回顾性队列研究基于法国国家医疗保险数据库,纳入2010年1月1日至2015年12月31日期间接受体外受精(IVF)的全部多发性硬化(MS)女性,以每名女性自身为对照,比较IVF后3个月暴露期与IVF前未暴露期。共225名女性、338次IVF操作;总体上IVF前后复发风险无增加(每患者年复发率0.20 vs 0.18;至少一次复发的IVF比例7.7% vs 7.1%),各亚组亦然。作者认为维持疾病修正治疗至IVF似乎是降低复发风险的决定性因素,MS女性应得到安慰,因为未显示IVF后(无论使用促性腺激素释放激素激动剂还是拮抗剂)需使用皮质类固醇治疗的复发风险增加。

要点

  • 总体IVF前后每患者年复发率0.20 vs 0.18,至少一次复发的IVF比例7.7% vs 7.1%,未见复发风险增加。
  • 亚组分析(按刺激方案及IVF结局)同样未见复发风险增加。
  • 维持疾病修正治疗至IVF的女性IVF前后年化复发率均较低。

核心结论

  • 维持疾病修正治疗至IVF似乎是降低复发风险的决定性因素。
  • MS女性应得到安慰,因为未显示IVF后需使用皮质类固醇治疗的复发风险增加,无论使用GnRH激动剂还是拮抗剂。

研究设计与样本

  • 回顾性队列研究,使用法国国家医疗保险数据库,纳入2010年1月1日至2015年12月31日期间在法国接受IVF的全部MS女性。
  • 共225名女性、338次IVF操作;首次IVF平均年龄34.6±4.5岁;36%的女性在该期间至少接受2次IVF。
  • 以每名女性自身为对照,比较IVF后3个月暴露期与IVF前未暴露期。
  • 采用零膨胀泊松回归模型,调整IVF时年龄和是否使用DMT,并纳入女性随机效应;按刺激方案和IVF结局(妊娠或失败)进行亚组分析。

主要发现

  • 总体上IVF前后每患者年复发率0.20 vs 0.18,至少一次复发的IVF比例7.7% vs 7.1%,未见复发风险增加。
  • 亚组分析中同样未见复发风险增加。
  • 维持DMT至IVF的女性IVF前后年化复发率均较低。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Several studies have shown an increased risk of relapse after in vitro fertilization (IVF) in women with multiple sclerosis (MS), especially when a gonadotrophin-releasing hormone (GnRH) agonist stimulation protocol was used. Our objective was to investigate the risk of relapse after IVF in women with MS, overall and according to stimulation protocol (GnRH agonists vs antagonists), using data from the French national health insurance database. METHODS: This retrospective cohort study included all women with MS who have benefited from IVF between January 1, 2010, and December 31, 2015, in France. Three-month exposed periods after IVF were compared with unexposed periods before IVF, each woman being her own control. Four outcomes were considered: annualized relapse rate (ARR), proportion of IVF with relapse, difference in the number of relapses "after-before," and the delay from IVF to the first relapse. Relapses were identified by an algorithm based on MS-related hospital admissions and the use of corticosteroid therapy. Stimulation protocols and disease-modifying therapies (DMTs) were identified using drug claims. Zero-inflated Poisson regression models adjusted for age at IVF and the presence of DMT were used. A random effect on women was included because women may undergo multiple IVF procedures. Subgroup analyses by stimulation protocol and IVF outcome (pregnancy or failure) were conducted. RESULTS: A total of 225 women accounting for 338 IVF procedures were included (the mean age at the first IVF 34.6 ± 4.5 years; 36% of women underwent at least 2 IVF procedures during the period). No increase in the risk of relapse after IVF was found overall (before vs after IVF: 0.20 vs 0.18 relapse per patient-year; 7.7% vs 7.1% of IVF with women having at least one relapse) and in subgroups. A lower ARR before and after IVF was observed among women who remained treated until IVF. DISCUSSION: The maintenance of DMT until IVF seemed to be a determining factor in reducing the risk of relapse. Women with MS should be reassured because we did not show an increased risk of relapse requiring the use of corticosteroid therapy after IVF neither with GnRH agonists nor with GnRH antagonists.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Mainguy M, Tillaut H, Degremont A, et al. Assessing the Risk of Relapse Requiring Corticosteroids After In Vitro Fertilization in Women With Multiple Sclerosis. Neurology. 2022. PMID: 35953288. doi:10.1212/WNL.0000000000201027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。